Otomycosis Clinical Trial
Official title:
Antifungal Potential of Moringa Olifera-loaded Nanoparticles Against Otomycosis; Preparation, Characterization, and Clinical Evaluation
patients with Otomycosis were recognized by an ENT specialist. 20 patients were distributed randomly into two groups. The first group will be treated with Nystatin ear drops twice daily. The second group will be treated with Moringa ear drops. patients will be examined endoscopically by the ENT specialist. patient's swabs will be isolated and analyzed by ELISA.
Inclusion criteria: (1) Otomycosis . Exclusion criteria: 1. tympanic membrane perforation; 2. concurrent immune suppression, 3. and concurrent bacterial infection. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01993823 -
Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis
|
Phase 3 | |
| Completed |
NCT01547221 -
Effectiveness of 3% Boric Acid in 70% Alcohol Versus 1% Clotrimazole Solution in Otomycosis Patients
|
N/A | |
| Recruiting |
NCT05660382 -
Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis
|
Phase 3 | |
| Completed |
NCT03686397 -
SVT-15652 Otic Solution for the Treatment of Otomycosis.
|
Phase 3 | |
| Completed |
NCT06339294 -
Efficacy of Pyodine Soaked Gelfoam vs Single Topical Application of Clotrimazole in Otomycosis Treatment
|
Phase 1 | |
| Not yet recruiting |
NCT04824261 -
Effectiveness of 4% Boric Acid in Distilled Water Versus Clotrimazole Solution in Otomycosis Patients.
|
N/A | |
| Completed |
NCT04432376 -
Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)
|
Phase 2/Phase 3 | |
| Completed |
NCT03686384 -
SVT-15652 Otic Solution for the Treatment of Otomycosis
|
Phase 3 | |
| Completed |
NCT03130738 -
Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis
|
Phase 2 |